Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 45
Page 45 of 114 · 1029 articles
Summary Suspension: Emergency Action Against Your License
How medical boards suspend a license before any hearing, the imminent danger standard, and what happens at the expedited hearing t…
Upjohn Warnings: What Employees Must Be Told
An Upjohn warning tells an employee who the company's lawyer represents, who owns the privilege, and what happens if the company l…
The Responsible Corporate Officer Doctrine in Healthcare
Executives can face criminal liability for a company's violation without personal knowledge, based solely on their authority to pr…
NPDB Reports: Disputing and Adding a Statement
The NPDB dispute process under 45 CFR Section 60.21: what Secretary review can fix, and why a subject statement helps regardless o…
Pharmacist-in-Charge Liability for Pharmacy Violations
Most boards of pharmacy hold the PIC personally liable for store violations. What triggers board action, and how documented escala…
Wound Care Nurse Practitioner Billing Compliance
Independent versus incident-to billing for wound care NPs, and why the billing method must match your state's scope-of-practice la…
Telefraud Takedowns: How Legitimate Providers Get Included
DOJ telefraud takedowns charge platform executives and the prescribers who signed their orders. How inclusion happens, and how rea…
State Telehealth Modality Requirements
States disagree on whether audio-only visits satisfy telehealth exam rules, creating licensure and false claims exposure for multi…
Worthless Services Claims Under the FCA
Worthless services claims treat reimbursement as false because the care itself had no value, not because it was miscoded or unneed…